Correlation Between Stoke Therapeutics and MeiraGTx Holdings

Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and MeiraGTx Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and MeiraGTx Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Stoke Therapeutics and MeiraGTx Holdings PLC, you can compare the effects of market volatilities on Stoke Therapeutics and MeiraGTx Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of MeiraGTx Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and MeiraGTx Holdings.

Diversification Opportunities for Stoke Therapeutics and MeiraGTx Holdings

-0.32

Correlation Coefficient

Stoke Therapeutics  MeiraGTx Holdings

Very good diversification

The 3 months correlation between Stoke and MeiraGTx is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and MeiraGTx Holdings PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MeiraGTx Holdings PLC and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with MeiraGTx Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MeiraGTx Holdings PLC has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and MeiraGTx Holdings go up and down completely randomly.

Pair Corralation between Stoke Therapeutics and MeiraGTx Holdings

Given the investment horizon of 90 days Stoke Therapeutics is expected to under-perform the MeiraGTx Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Stoke Therapeutics is 1.04 times less risky than MeiraGTx Holdings. The stock trades about -0.07 of its potential returns per unit of risk. The MeiraGTx Holdings PLC is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest  391.00  in MeiraGTx Holdings PLC on September 3, 2024 and sell it today you would earn a total of  286.00  from holding MeiraGTx Holdings PLC or generate 73.15% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Stoke Therapeutics  vs.  MeiraGTx Holdings PLC

Stoke Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Stoke Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

MeiraGTx Holdings PLC

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in MeiraGTx Holdings PLC are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, MeiraGTx Holdings showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Stoke Therapeutics and MeiraGTx Holdings

The main advantage of trading using opposite Stoke Therapeutics and MeiraGTx Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, MeiraGTx Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MeiraGTx Holdings will offset losses from the drop in MeiraGTx Holdings' long position.

The idea behind Stoke Therapeutics and MeiraGTx Holdings PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.